Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use
- 28 February 2009
- journal article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 31 (2), 347-359
- https://doi.org/10.1016/j.clinthera.2009.02.019
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Post-opioid receptor adaptations to chronic morphine; Altered functionality and associations of signaling moleculesLife Sciences, 2006
- A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or kneeClinical Therapeutics, 2006
- Oxymorphone Extended-Release Tablets Relieve Moderate to Severe Pain and Improve Physical Function in Osteoarthritis: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase III TrialPain Medicine, 2005
- Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III studyThe Journal of Pain, 2005
- Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot studySupportive Care in Cancer, 2004
- Demographics, Assessment and Management of Pain in the ElderlyDrugs & Aging, 2003
- Evidence For and Against the Use of Opioid Analgesics for Chronic Nonmalignant Low Back Pain: A Review: Table 1Pain Medicine, 2002
- Accuracy in Equianalgesic Dosing: Conversion DilemmasJournal of Pain and Symptom Management, 2001
- Opioid therapy for chronic nonmalignant pain: a review of the critical issuesJournal of Pain and Symptom Management, 1996
- Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ designPain, 1995